Rollins, Inc.（ROL） · Business Services

Rollins Deep Value Investment Research Report

May 29, 2026·~20 min read

Quick ReadPlain-language overview · read this first

Rollins owns brands including Orkin, Clark, and HomeTeam, charging more than 2.8 million residential and commercial customers worldwide for recurring inspections and termite, rodent, and wildlife control, with more than 850 branches forming a nationwide service network. This is a cash machine with essential demand, extremely low capital intensity, and more than 80% recurring revenue: in 2025, $3.76 billion of revenue produced $650 million of free cash flow, and growth has continued for 98 consecutive quarters. That is exactly why the report assigns only Watch. The tension is entirely in the price. As of May 28, 2026, the share price was $49.42, the trailing P/E was about 45 times, and the free cash flow yield was only 2.6%, below even the 10-year Treasury yield of 4.45%. The report estimates conservative owner earnings of about $600 million and fair intrinsic value at $40-50; the current price is already at the upper end, or even slightly above it: too high a premium has been paid for a good company. The risk is not in the business itself. It lies in the possibility that a 45 times multiple contracts to 30 times, while insurance and labor costs rise, a 38% family voting stake, and the governance discount from the 2022 SEC accounting settlement all weigh on the stock. A 30%-45% drawdown would not be surprising. The report concludes that the margin of safety is insufficient, with an ideal buy range of $35-42.

Lead
Rollins is the pest-control leader with exceptional business quality, recurring revenue, low capital intensity, and durable cash generation. The core thesis is that Orkin, national density, standardized operations, and disciplined acquisitions make it a rare long-term compounder, while a roughly 45x earnings multiple already prices in many years of strong growth. Rating Watch: a high-quality company, but the ideal buy range is $35 to $42.

Full report

Prices in the article are as of publication; see the valuation band above for the live price.

Note: the discussion below separates facts, assumptions, inferences, and opinions as much as possible. Items with citations are verifiable facts; valuation inputs are explicitly labeled as assumptions; judgments extended from facts are labeled as "inferences"; the final rating is an "opinion."

Conclusion First

My investment rating for Rollins is Watch. Opinion: Rollins is a good business I would be willing to own for the long term, but not at any price. In pest control, an industry with long-duration demand, high repeat usage, and low capital expenditure needs, the company has used brands such as Orkin, a national network, process-driven operations, and a diversified customer base to compound revenue and cash flow at a rare pace. But as of May 28, 2026, ROL traded at about $49.42, with a market value of about $23.79 billion and a trailing P/E of roughly 45.3x. That is no longer the typical range for "buying a business at a low price."

At the core of the judgment, fact: in 2025, the company generated revenue of $3.761 billion, operating profit of $726 million, net income of $527 million, operating cash flow of $678 million, and free cash flow of $650 million. In Q1 2026, revenue grew 10.2% year over year, including organic growth of 6.6%, but operating margin fell 120 basis points year over year to 16.1%; management attributed the pressure to insurance and claims, labor costs, and sales investment. The company also emphasized that "recurring and ancillary service revenue" accounted for more than 80% of total revenue, and in 2026 investor communications it reiterated medium-term targets of 7%-8% organic growth, 2%-3% acquisition growth, and free cash flow conversion above 100%. Inference: this points to very high business quality, but the current price already embeds many years of sustained high-single-digit growth and high cash conversion. For a long-term investor who is balanced but conservative, the most likely mistake is not buying a bad company; it is paying too high a price for a good one.

As for whether the current price offers a margin of safety, my judgment is not obviously. Opinion: if you already hold it from an earlier, lower cost basis, I do not view this as an ordinary company that needs to be sold lightly. But for new capital today, I would rather put it on a high-quality watchlist than buy a large position outright. The key background behind this view is that ROL's trailing free cash flow yield is only around 2.6%, while the U.S. 10-year Treasury yield was about 4.45% on May 28, 2026. In other words, the current share price requires a high degree of confidence in long-term future growth.

In terms of suitable investor types, it is more suitable for quality-first long-term value investors who are willing to track operating quality and acquisition discipline over time. It is less suitable for conservative investors who put "margin of safety" first and want a clear undervaluation buffer at purchase. Inference: ROL is more like "a good company waiting for a good price" than "a cheap company waiting for mean reversion."

There are three largest uncertainties. First, valuation compression risk: the current valuation is no longer cheap. Second, acquisition and margin execution risk: the company depends on ongoing acquisitions to supplement growth by 2%-3%, and Q1 2026 margins were already disturbed by insurance and labor costs. Third, governance and capital allocation discount: the company has strong family control, historical accounting-control issues, and a CFO transition in 2026.

Business Understanding

What is the core business? Fact: Through brands including Orkin, Fox Pest Control, Northwest Exterminating, Clark Pest Control, HomeTeam, and Critter Control, Rollins provides residential and commercial customers with pest control, termite protection, rodent control, wildlife control, and related ancillary services. As of May 2026, the company served more than 2.8 million customers globally, had more than 850 company-owned and franchised locations, and employed about 22,000 people.

Who are the customers, and how does the company charge? Fact: Customers include both residential users and commercial clients. Revenue comes from regular inspections, ongoing pest control, termite protection, and ancillary one-time projects. In Q1 2026, residential, commercial, and termite and ancillary service revenue all grew year over year, with residential up 9.3%, commercial up 9.6%, and termite and ancillary services up 13.5%.

Is the revenue recurring, stable, and predictable? Fact: Management disclosed that the company's "recurring and ancillary service revenue" accounts for more than 80% of total revenue. Q1 2026 was the company's 98th consecutive quarter of revenue growth. At its 2026 investor day, the company said it had achieved 25 consecutive years of revenue and adjusted EBITDA growth. Inference: This is not a business that relies on large orders, project work, or cyclical upswings. It is a cash-flow machine built from many small, diversified, recurring, necessity-driven service contracts. Its stability is higher than that of most consumer and industrial companies.

What is the cost structure? Fact: Taking Q1 2026 as an example, costs mainly consisted of frontline employee expenses, materials and supplies, insurance and claims, fleet expenses, sales and marketing expenses, and back-office administrative expenses. On the cost side, the most important items to watch are labor, insurance, and fleet. The company's gross margin in Q1 was 50.8%, down 60 basis points year over year; SG&A was 31.2% of revenue, up 70 basis points year over year.

Does it depend on a small number of customers, suppliers, channels, policies, or key people? Fact: The company disclosed in its 10-K that overall accounts-receivable credit risk is low because the customer base consists of a large number of diversified customers with broad geographic distribution. At the same time, most chemicals and products used by the company are generally available from multiple sources, and historically the company has been able to find substitutes during supply disruptions. Inference: This means ROL does not have the typical vulnerability of a "single large customer" or "single core supplier." The truly important assets are not any one customer, but brand, route density, processes, training systems, and the local operating network.

Is this business simple, transparent, and easy to understand? If the stock market closed for 5 years, would I be willing to hold it? Opinion: I think yes. Pests do not disappear because of the economic cycle; homes do not stop needing termite protection because the stock market is closed; restaurants, hotels, warehouses, food production facilities, and residential properties will not abandon compliant vector control. But one point must be added: being willing to hold this business for the long term does not mean being willing to buy the stock at any valuation.

Business understandability score: 5/5.

Industry and Competitive Landscape

What stage is the industry in? Is long-term demand stable? Fact: IBISWorld estimates that the U.S. pest control industry had a market size of about $29.7 billion in 2026, with an industry CAGR of about 3.4% from 2021 to 2026. The same source lists the leading U.S. industry companies as Rentokil, Rollins, and Ecolab. In its 2026 investor presentation, Rollins management described its serviceable market as more than $20 billion and emphasized that demand is supported by long-term factors such as changing consumer preferences and rising adoption. Inference: This is a mature industry with continuing structural growth, not an explosive emerging sector. The benefit is steadier demand and lower failure probability; the drawback is that valuation should not be built on "revolutionary growth."

Is the industry vulnerable to disruption from technology, regulation, or changes in consumer habits? Fact: In its 10-K, the company emphasizes that the business is affected by multiple categories of regulation, including environmental, consumer-protection, labor, vehicle, and safety regulations. It also mentions that climate change and broader data/privacy regulations may increase compliance costs. The company also acknowledges that termite claims, litigation, rising insurance costs, and seasonal weather changes may affect results. Inference: The industry will be reshaped by technological improvements in monitoring, routing, digital marketing, and data-driven scheduling, but it is hard to see "software" completely disrupting it. The real risks come more from regulation, insurance, labor, and execution than from "an app appearing tomorrow and wiping out the industry."

What does the competitive landscape look like? What is the company's position in the industry? Fact: The U.S. industry is highly fragmented. IBISWorld counts 34,076 companies in the U.S. industry in 2026. NPMA's 2025 industry study counts 16,565 pest-control companies, of which 81.4% have only one or two locations. The two datasets use different definitions, but they point to the same conclusion: the industry is extremely fragmented, with a very long tail. Rollins has a multi-brand, multi-region network and views acquisitions as a source of 2%-3% annual medium-term growth. Inference: In this type of industry, the advantage of the leading company is not "monopoly." It is stronger branded customer acquisition, lower unit management costs, more standardized training, better recruiting, and faster absorption of acquisition targets. This also explains why Rollins can compound over time while many small local companies remain regional businesses.

Does the company have pricing power? Is the industry profit pool concentrated? Fact: Rollins' 2024 gross margin improved to 52.7%, up 50 basis points from 2023, and the company explicitly stated that "pricing exceeded inflationary pressure." In 2025 investor communications and its 2026 outlook, management continued to identify pricing as a core growth and margin lever. Inference: ROL has modest but persistent pricing power. This is not the one-time sharp price increase of a luxury product. It is the ability to raise prices slightly each year while keeping customer churn manageable, which is very important for long-term compounding.

Is this a "good company in a good industry" or an "excellent company in a poor industry"? Opinion: It is closer to an "excellent company in a moderately attractive industry." The industry itself does not have the exceptionally strong structural moat of software or payment networks, but demand is stable, fragmented, and consolidatable. Rollins has turned an originally ordinary service industry into a high-cash-return compounding platform.

Industry attractiveness score: 4/5.

Moat and Management

Moat analysis I break Rollins' moat into ten components:

Brand advantage: yes.

Fact: The company owns more than 450 trademarks. Its 10-K even states explicitly that although competitive advantages also come from technology, marketing, and sales capabilities, the loss of the Orkin trademark could have a material effect on the overall business.

Cost advantage: yes, but not raw-material cost; operating cost.

Inference: The real cost advantage in this industry comes from route density, recruiting and training systems, shared back-office functions, advertising efficiency, and branch management, not from buying chemicals a few cents cheaper. Rollins' national multi-brand network and acquisition platform make it easier to spread management expenses and technology investment. The company also repeatedly frames "modernization" and ongoing operating discipline as levers for margin improvement.

Scale advantage: yes.

Fact: Rollins serves more than 2.8 million customers, has more than 850 locations, and employs about 22,000 people.

Network effects: weak.

Opinion: It is not Visa, and it is not a software platform. More customers do not make each customer unable to leave ROL, but more customers do make the company better suited for density-based operations and branch integration.

Switching costs: medium.

Inference: Pest-control contracts are often not large at the individual level, and customers can theoretically switch vendors. But in termite protection, commercial compliance, brand trust, service continuity, and the psychology of "I do not want to test a home-risk issue through trial and error," actual switching costs are higher than they appear.

Channel advantage: yes.

Inference: The coexistence of national brands, regional brands, and local branches gives the company both centralized capabilities and local service attributes.

Patent/license/regulatory barriers: present, but not absolute.

Fact: The industry is subject to multiple categories of environmental, safety, labor, and consumer regulations. Inference: Regulation makes it harder for small companies to standardize processes, but it does not directly prevent competitors from entering.

Data advantage: limited but improving.

Inference: The company has data on customers, routes, renewals, customer acquisition, and service history, but this is not yet enough to form an exclusive data moat. Its role is more in operational optimization than in "something others cannot replicate."

Culture or operating capability: strong.

Fact: The company repeatedly emphasizes training, teammate development, The Rollins Way, customer and team retention, and process modernization, and directly links these to customer experience and long-term growth. Inference: This is one of Rollins' most important but hardest-to-quantify moats.

Capital allocation capability: above average, but not perfect.

Fact: The company supports high cash flow with low capital expenditures and continues to allocate cash through dividends, acquisitions, and limited buybacks. In secondary offerings in 2023 and 2025, it repurchased shares from major shareholders/sellers totaling about $500 million, with the 2023 repurchase price at about $34.39 and the 2025 repurchase price at about $56.93. Inference: The 2023 buyback was excellent. The 2025 buyback, from today's perspective, was not cheap. This suggests the company's capital allocation is generally rational, but should not be idealized.

Is the moat widening, stable, or narrowing? Opinion: My judgment is stable to slightly widening. The reason is that the industry remains fragmented, the company still has acquisition runway, and brand and operating advantages can still be monetized. But because this is a service industry, it will not "automatically get stronger as it scales" in the way a platform company can.

How long and how much capital would competitors need to replicate it? Inference: Replicating Orkin-level national awareness, a multimillion-customer base, a branch network, and training and dispatch systems is not something that can be done in a few years simply by spending money. But replicating a strong local pest-control company in a single city is not difficult. That is exactly why the industry has long been a coexistence of "national leaders plus many strong local players."

Can it raise prices in an inflationary environment? Can it remain profitable in an economic downturn? Fact: In 2024, the company explicitly stated that pricing exceeded inflationary pressure. In 2025 and 2026, management continued to treat price as an important driver of growth and profit. The company also emphasizes its high recurring-revenue mix. Inference: ROL can raise prices, but it is not fully immune to cost pressure. It is highly likely to remain profitable in a weak environment, but one-time business, termite, and weather-related work will fluctuate.

Is management trustworthy, and is capital allocation rational? Positive facts: the company has separated the CEO and chair roles; executives and directors have clear stock ownership requirements; the company prohibits executives and directors from hedging or pledging stock and has bonus clawback mechanisms. Negative facts: first, the company has strong family control, with an important shareholder group controlling about 38% of voting power; second, in 2022 the company settled with the SEC over accounting controls and earnings management issues, paying an $8 million penalty, and the SEC stated that it lacked sufficient internal controls across several reserve accounts, manual entries, and period-end adjustments; third, the company has related-party arrangements that are fully disclosed but still worth watching. Mitigating fact: the 2022 annual report also disclosed immaterial revisions to the accounting treatment of certain acquisitions, but the company later reported effective internal control again in its 2025 10-K, and the auditor also issued an effective ICFR opinion. Inference: My conclusion is: management has strong operating capability, but governance does not deserve a full score. By the standard of "whether it is worth being a long-term business owner," I am willing to trust the team to continue operating the business well. By the standard of "whether there is no governance discount at all," the answer is no.

Management and capital allocation score: 3/5. If looking only at operating execution, I would score it higher. Including the 2022 SEC matter, family control, and the 2025 high-price buyback, I think 3/5 is more honest.

Moat strength score: 4/5.

Financial Quality and Owner Returns

The financial profile over the past several years is very clear: high growth, high cash conversion, low capital expenditure, modest buybacks, and consistent dividends. Fact: From 2019 to 2025, the company's revenue increased from $2.015 billion to $3.761 billion, a 6-year CAGR of about 11.0%; net income increased from $203 million to $527 million, a CAGR of about 17.2%; free cash flow increased from about $292 million to $650 million, a CAGR of about 14.2%.

The table below summarizes key verifiable financial metrics. 2019-2021 data come from the 2021 annual report, 2022 data from the 2022 annual report, 2023 data from the 2023 annual report, 2024 data from the 2024 annual report, and 2025 data from the 2025 10-K.

Year	Revenue, $bn	Net Income, $bn	Operating Cash Flow, $bn	Free Cash Flow, $bn	FCF/Net Income	Diluted Shares, mn	Dividend per Share, $
2019	2.015	0.203	0.320	0.292	143.8%	491.2	0.31
2020	2.161	0.267	0.436	0.413	154.7%	491.6	0.33
2021	2.424	0.357	0.402	0.375	105.1%	492.1	0.42
2022	2.696	0.369	0.466	0.435	118.1%	492.4	0.43
2023	3.073	0.435	0.528	0.496	114.0%	490.1	0.54
2024	3.389	0.466	0.608	0.580	124.4%	484.3	0.615
2025	3.761	0.527	0.678	0.650	123.4%	484.1	0.6775

Margins, capital returns, and cash conversion Fact: From 2022 to 2025, operating margin increased from 18.3% to 19.3%, and net margin rose from 13.7% to around 14.0%. In 2025, operating cash flow and free cash flow were about 128.8% and 123.4% of net income, respectively. Based on my simplified calculation using year-end shareholders' equity, debt, and cash, the company's ROE from 2022 to 2025 was roughly 31%-39%, ROA about 17%-18%, and simplified ROIC about 30%. This must be emphasized: ROIC is my approximate estimate based on public financial statements, not a company-reported metric.

Balance sheet, leverage, and interest coverage Fact: As of the end of 2025, the company had total assets of $3.141 billion and shareholders' equity of $1.374 billion. As of the end of March 2026, total assets were $3.160 billion and shareholders' equity was $1.382 billion. At the end of March 2026, short-term debt, in the form of commercial paper, was about $164 million, and long-term debt net was about $487 million. The company disclosed a lease-adjusted leverage ratio of about 0.9x. 2025 operating profit was $726 million, net interest expense was $28.56 million, and interest coverage was about more than 25x. Inference: For a service-oriented acquisition platform, this is a quite healthy balance sheet. It is not "zero leverage," but it is far from a level that would raise concern about debt service capacity.

Receivables, inventory, payables, and working capital Fact: In the 2025 operating-cash-flow bridge, trade receivables reduced cash by about $36.40 million, finance receivables reduced cash by about $21.50 million, materials and supplies reduced cash by about $1.70 million, changes in accounts payable and accrued expenses were -$9.50 million, and deferred revenue increased by about $2.70 million. Although working capital consumed cash as the business grew, operating cash flow still reached $678 million. In Q1 2026, operating cash flow declined year over year, mainly affected by the timing of tax payments and changes in the method of interest payment. Inference: The company's profits are broadly real cash, not something "manufactured" by stretching payables, compressing expenses, or collecting unusually.

Buybacks, dividends, and share count Fact: Dividends per share increased continuously from 2019 to 2025. In 2023, the company repurchased shares sold by a major shareholder for about $300 million at about $34.39 per share; in 2025, it repurchased related shares sold for about $200 million at about $56.93 per share. At the same time, the company did not conduct regular open-market repurchases in 2025 or 2024. Diluted shares decreased from 492.4 million in 2022 to 484.1 million in 2025, a small decline but in the right direction. Inference: Rollins' shareholder returns mainly come from dividends + internal compounding + acquisition expansion, not large-scale buybacks.

Are there signs of financial fraud, aggressive accounting, or earnings manipulation? Fact: There were indeed warning signs historically. In 2022, the SEC charged the company with using improper accounting to increase quarterly EPS to meet analyst expectations and stated that it lacked sufficient internal controls over several reserves, manual entries, and period-end adjustments. The company ultimately paid an $8 million penalty to settle. The company subsequently disclosed immaterial revisions to accounting for certain historical acquisitions and in later annual reports again reported effective ICFR. Opinion: My conclusion is therefore not "no issue at all," but rather: there were problems historically, but the public evidence currently indicates remediation, and overall cash quality in the financial statements is good. This matter should not be ignored, but it should not be exaggerated to negate all current operating quality.

Owner Earnings analysis I estimate "Owner Earnings" using a deliberately conservative approach:

Fact: 2025 operating cash flow was $678.1 million, capital expenditure was $28.09 million, and stock-based compensation expense was $39.71 million.
Assumption: Because the company does not separately disclose "maintenance capital expenditure," I conservatively treat all capital expenditure as maintenance capital expenditure. I also treat stock-based compensation as a real economic cost, not as "free cash."
Inference: Therefore, conservative 2025 Owner Earnings ≈ operating cash flow $678.1 million - capital expenditure $28.1 million - stock-based compensation $39.7 million = $610 million.
Fact + inference: based on a market value of $23.79 billion on May 28, 2026, the current price is equivalent to about 39x conservative Owner Earnings.

My judgment: ROL's profits are very likely "cash profits," not merely accounting profits. The company also does not obviously have the trait of needing more money as it grows. On the contrary, it looks more like a business that throws off more cash as it grows. The real issue to watch is not cash generation, but how much price you pay for that cash generation.

Intrinsic Value and Margin of Safety

Owner Earnings Discount Method

Here I use a conservative Owner Earnings base of about $600 million to $610 million, and I explicitly label valuation parameters as assumptions, not facts.

Scenario	Starting Owner Earnings	Growth Over Next Ten Years	Discount Rate	Terminal Growth	Implied Intrinsic Value per Share
Conservative	$600 million	5%	8.5%-9.0%	3.0%	about $28-$35
Neutral	$600 million	7%	8.0%	4.0%	about $40-$50
Optimistic	$600 million	9%	7.5%	4.5%	about $60-$70

Opinion: I am more willing to view $40-$50 per share as a "relatively reasonable" neutral value range and $35-$42 per share as a buy range more consistent with the requirements of conservative investors. ROL's current price of about $49.42 is already close to, or even slightly above, the upper end of my neutral valuation.

A very important reverse-engineering exercise Inference: If you use looser assumptions, such as starting from the company's reported free cash flow rather than my more conservative Owner Earnings, the current price roughly corresponds to "acceptable but not cheap." But as soon as you raise the discount rate a little or lower growth expectations a little, the current price quickly loses its margin of safety. This shows that the most fragile part of the valuation is not current profit, but confidence in sustained high compounding over the next ten years.

Relative Valuation Method

Public-market comparables are imperfect because there are few pure-play listed pest-control companies, but Rentokil and Ecolab can still provide a rough comparison. Below is a public-market snapshot from around the end of May 2026: ROL's current P/E was about 45.3x; Ecolab's P/E was about 35.2x; Rentokil's U.S.-listed ADR market value was about $76.9 billion, and public market data services showed a P/E of about 32.7x and EV/EBITDA of about 15.5x. ROL's EV/EBITDA and P/FCF were also clearly above these comparables.

Company	Current Characteristics	P/E	EV/EBITDA	P/FCF	My Interpretation
Rollins	High quality, asset-light, sustained compounder	about 45x	about 29-31x	about 39-41x	Quality premium is very high
Ecolab	More diversified, larger scale	about 35x	about 20-21x	about 39-44x	Valuation is high, but below ROL
Rentokil	Larger scale, but heavier integration burden	about 33x	about 15-16x	about 20-25x	Much cheaper, but quality/execution is below ROL

Opinion: ROL does deserve a premium because its growth quality, cash conversion, and operating discipline are better than those of most traditional service companies. But the current premium is already substantial. A conservative investor should not automatically accept ROL's high valuation just because "peers are not cheap either."

Asset or Liquidation Value Method

Fact: As of the end of 2025, Rollins had goodwill of about $1.4 billion. As of the end of March 2026, shareholders' equity was about $1.382 billion, while net amortizable intangible assets were about $409 million. Inference: This means that from a "tangible net assets/liquidation value" perspective, ROL is not cheap. One could even say it has almost no asset-based safety cushion. This is not a stock supported by land, cash, inventory, or factories. Its value is mainly created by customer relationships, brand, route density, and operating systems. Opinion: ROL is therefore a typical earning power valuation case, not an asset play.

Final Valuation Judgment

Conservative intrinsic value range:$28-$35 per share
Reasonable intrinsic value range:$40-$50 per share
Optimistic intrinsic value range:$60-$70 per share
Current price relative to intrinsic value: clearly expensive versus conservative valuation; near the upper end of reasonable versus neutral valuation; still with room versus optimistic valuation, but that requires almost no major mistakes for many future years.
Required margin of safety: for an investor like you, "balanced but conservative, with a holding period of more than 10 years," I think at least 20%-25% is required.
Ideal buy price range:$35-$42
Acceptable holding price range:$42-$55
Clearly overvalued price range:above $60

Risks, Comparison, and Final Conclusion

Most important risks

First, overvaluation risk. Fact: The current P/E is about 45x, and the market has clearly priced in high quality and long-term compounding. Inference: Even if the company continues to improve, if growth is slightly below expectations or the multiple the market is willing to pay falls from 45x to 30x, you may still earn very ordinary returns for several years.

Second, competition and execution risk. Fact: Although the industry is fragmented, Rentokil, Ecolab, and many local companies all compete in it. Rollins itself also lists acquisitions as a medium-term source of 2%-3% growth. Inference: If acquisition prices become increasingly expensive, integration returns decline, or marketing efficiency deteriorates, ROL's high valuation will be hard to sustain.

Third, risk that technology and the business model weaken traditional advantages. Opinion: I do not think there is a major risk that "pest-control services are directly replaced by software." However, digital customer acquisition, monitoring hardware, and more transparent pricing will make industry competition more efficient and may compress some traditional advantages over the long term.

Fourth, regulatory, insurance, and claims risk. Fact: The company explicitly discloses risks related to environmental, safety, consumer-protection, labor, climate disclosure, termite claims, and rising insurance costs. Q1 2026 margins were also already affected by insurance and claims-cost pressure.

Fifth, governance and accounting risk. Fact: The 2022 SEC matter shows the company has not been free of governance flaws historically. At the same time, strong family control of about 38% of voting power limits the influence of outside shareholders.

Sixth, management transition risk. Fact: In May 2026, the company announced that CFO Kenneth Krause would leave in mid-June and William Harkins would succeed him. Inference: This is not necessarily bad, but for a company emphasizing modernization, capital structure, and investor transparency, it is at least worth monitoring continuously.

Strongest bear case If I were short, I would say this: Rollins may indeed be an excellent company, but what you are buying today is not the "excellent company" alone; it is "excellent company + very high valuation." The industry is not an irreplaceable super-platform industry, and future margins will still be affected by insurance, labor, marketing, weather, and acquisition prices. The company also had an SEC accounting-control incident historically. So the bear would say: you are taking governance risk, execution risk, and valuation risk without getting a cheap price. I think this bear case is valid.

What facts would overturn the investment judgment?

Organic growth falling below 4% for a sustained period, where the issue is not merely weather disruption.
Clear deterioration in renewal quality or recurring-revenue structure.
Pricing no longer covering rising labor, insurance, and customer-acquisition costs.
Acquisition returns declining, obvious goodwill impairment appearing, or leverage rising because of acquisitions.
Another serious internal-control, accounting, or related-party controversy.
Management sacrificing per-share value growth for "scale."

Comparison with other opportunities

Compared with strongest competitor Rentokil:

Fact: Rentokil's 2025 pest control revenue was about $5.703 billion, with organic growth of about 2.6% and North America organic growth of about 2.2%. ROL's 2025 revenue was $3.761 billion, organic growth was 6.9%, and Q1 2026 organic growth was 6.6%. Opinion: Rollins is clearly the higher-quality operating entity, but Rentokil is cheaper. I want the higher-quality company, preferably at a cheaper price.

Compared with a broad market index:

Opinion: If you are not confident in your ability to track the pest-control industry, acquisition discipline, governance changes, and margin details over the long term, a broad market index offers greater diversification benefits. ROL's business quality is better than that of many index constituents, but a single stock has lower valuation tolerance.

Compared with the risk-free rate:

Fact: The U.S. 10-year Treasury yield was about 4.45% on May 28, 2026. Based on market value and trailing free cash flow around the end of May 2026, ROL's free cash flow yield was roughly 2.6%. Inference: This means you buy ROL not for current cash yield, but because you believe it can continue compounding at a high rate in the future. If you are unsure about the certainty of that high compounding, Treasuries/high-grade bonds currently have more of a "certainty premium."

If I could hold only 5 assets, would it qualify?

Opinion: The business quality qualifies; the current price does not. In other words, it is a company "worth putting into the Top 5 candidate pool," but not a price "worth buying today with a Top 5 position."

Investment Checklist

Question	Conclusion
Can I understand this business?	Pass
Does it have stable long-term demand?	Pass
Does it have a durable moat?	Pass
Does it have pricing power?	Pass
Can it generate stable free cash flow?	Pass
Are its returns on capital excellent?	Pass
Is management trustworthy?	Uncertain
Is capital allocation rational?	Uncertain
Is the balance sheet sound?	Pass
Is valuation below intrinsic value?	Fail
Is the margin of safety sufficient?	Fail
Would I feel comfortable holding it long term?	Pass at the business level; uncertain at the price level
What key facts would make me sell?	Listed above: deterioration in growth, pricing, controls, leverage, and acquisition returns
Do I want to buy only because the share price has risen or market sentiment is strong?	Uncertain; self-checking is especially important at the current price

Final Investment Conclusion

Final rating: Watch

One-sentence investment thesis Rollins is a high-quality, resilient, asset-light pest-control leader capable of long-term compounding, but the current share price already embeds considerable optimism about many years of future high growth, leaving insufficient margin of safety.

Core bullish reasons

High recurring-revenue mix, stable long-term industry demand, and diversified customers.
Extremely low capital expenditure, free cash flow consistently above net income, and excellent cash quality.
Brand, route density, training, and operating systems form a real moat.
Low leverage and strong interest coverage leave room for continued acquisitions and dividends.

Core bearish reasons

Current valuation is high, with low tolerance for error.
Q1 2026 already showed that margins do not only move upward.
Family control and the historical SEC accounting-control matter mean governance cannot be treated as "full-score model student" quality.
Repurchasing shares at a relatively high price in 2025 shows capital allocation is also affected by timing.

Key assumptions

Organic growth remains near the high-single-digit range over the next ten years.
Pricing power continues to cover wages, insurance, marketing, and fleet costs.
Acquisitions continue to create value rather than dilute returns.
No new major internal-control/governance incident appears.

Reasonable buy price $35-$42 per share. Under my conservative Owner Earnings and 20%-25% margin-of-safety requirement, this is the more comfortable range.

Target holding period More than 10 years. This is not a stock for making money from short-term valuation repair; it is a business suited to long-term compounding.

Expected annualized return The following are my scenario estimates, not company guidance:

Conservative scenario: about 3%-5%
Neutral scenario: about 6%-8%
Optimistic scenario: about 9%-11%

Maximum loss risk Opinion: If growth slows, margins come under pressure, and valuation compresses from 45x P/E to 25-30x over the next 2-3 years, a 30%-45% medium-term drawdown in the share price would not be surprising. If governance/accounting problems reappear on top of that, an even larger decline in an extreme scenario cannot be ruled out. The real source of permanent capital loss is buying at a high price + the compounding assumption being falsified, not the business itself suddenly disappearing.

Tracking indicators

Organic revenue growth rate
Segment growth rates for residential, commercial, termite, and ancillary services
Operating margin and adjusted EBITDA margin
Insurance and claims expense ratio
Sales and marketing expense ratio
Operating cash flow / net income
Free cash flow conversion rate
Acquisition spending and post-acquisition returns
Net debt / EBITDA and lease-adjusted leverage
Customer retention, employee retention, and management changes

Signals that would trigger reassessment

Organic growth significantly below the industry for several consecutive quarters
Gross margin and operating margin continuing to decline while pricing fails
Acquisition premiums too high and goodwill impairment rising
Leverage rising materially
Another internal-control, accounting, or related-party controversy
Management putting "scale growth" above "per-share intrinsic value growth"

Final recommendation If you look at ROL with the mindset of "owning a business for the long term," I would say: this is a company worth studying for a long time and even worth owning for a long time; but at today's price, I prefer restraint rather than rushing in. For a balanced but conservative investor with a horizon of more than 10 years, the most rational action is not to deny Rollins, but to recognize its excellence while refusing to pay too large a premium for that excellence.

Open questions and limitations Among public sources, there are few pure-play listed pest-control comparables, and market-share definitions differ across institutions. The company does not separately disclose maintenance capital expenditure, so Owner Earnings and ROIC can only be conservatively estimated, not presented as precise figures. This uncertainty does not change my broad judgment of "excellent company, ordinary price," but it does affect the precision of the valuation range.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.

Mentioned Tickers

RTO ECL

Baillie Framework · Ten Questions for Growth Investing

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

How large is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?6/10

Conclusion: Rollins has a meaningful market ceiling, but this is about share gains, pricing, category penetration, and acquisition-led consolidation in a mature pest control services market, rather than the creation of a brand-new market. The report frames the U.S. pest control industry as a mature but resilient service sector, and external data supports that view: IBISWorld estimates the 2026 U.S. pest control market at 29.7 billion dollars, with a 2021-2026 compound growth rate of 3.4%; under the NPMA/Specialty Consultants framework, 2025 U.S. structural pest control service revenue was 13.416 billion dollars, up 6% year over year, while 81.4% of 16,565 companies had only one or two locations. This means the pie is still growing slowly, while the larger opportunity comes from a fragmented market concentrating toward professional leaders. For Baillie Q1, the key question is not whether demand will explode from zero to one, but whether the leader can sustain share migration faster than the industry for many years.

Rollins already has substantial scale: 2025 revenue was 3.761 billion dollars, including 3.491 billion dollars in the U.S.; residential and commercial pest control services are primarily recurring monthly, bi-monthly, or quarterly, and termite maintenance can also be renewed annually. At its 2026 investor day, management described the serviceable pest control market as more than 20 billion dollars, with a medium-term algorithm of 7%-8% organic growth plus 2%-3% acquisition growth. Overseas networks and ancillary services provide additional room, but revenue is still mainly U.S.-based, so international expansion looks more like a long-term option than the current main engine. From a Baillie perspective, this is a good but not spectacular ceiling: ROL can keep taking share, broadening services, and improving density, but it is refining, densifying, and consolidating an existing pie rather than opening an exponential new market.

Jun 8, 2026
Can its revenue at least double over the next five years? Will growth be driven mainly by volume, price, or new businesses?4/10

Conclusion: "At least doubling" revenue over the next five years should not be the base case; it is closer to a strong bull case. Starting from Rollins' 2025 revenue of 3.761 billion dollars and organic growth of 6.9%, reaching about 7.5 billion dollars would require nearly a 15% CAGR; the company's 2026 investor day medium-term algorithm is 7%-8% organic growth + 2%-3% acquisition growth, or roughly 9%-11% in total. That combination is strong, but after five years of compounding it points roughly to 5.8-6.3 billion dollars, still short of doubling. Q1 2026 revenue growth of 10.2% and organic growth of 6.6% also looks more like validation of this low-end double-digit algorithm, not a move onto a 15% step-up. In other words, the company can compound steadily, but "excellent growth" should not be upgraded into "certain doubling."

Breaking down the drivers, volume comes first: renewals in residential, commercial, and termite services, route density, higher customer penetration, and acquisition-led consolidation in a fragmented industry. Here, volume is not merely store count; it means more customers, higher service frequency, more ancillary projects, and acquired locations being brought into the Rollins system. Price comes second: the report says 2024 pricing outpaced inflation, but Q1 gross margin and operating margin were under pressure, showing that pricing has flexibility but is not unlimited, and is used more to cover wages, insurance, fleet, and customer acquisition costs. New businesses are more about extensions such as termite, ancillary, wildlife, digital dispatching, and cross-selling; in substance, they remain horizontal expansion of pest control services, not an independent second curve capable of revaluing TAM. From a Baillie perspective, Rollins is an excellent service platform compounding at high-single-digit organic growth plus modest M&A; to double in five years, organic growth would need a clear step-up, M&A would need to accelerate, and integration would need to avoid margin damage. That is an upside case, not an honest base case.

Jun 8, 2026
Five years from now, what will take over as the next growth engine? Does this "second curve" exist today?4/10

Conclusion: Five years from now, the most likely successor is not a brand-new S-curve, but a combined engine of "M&A + deeper commercial/termite and ancillary services + digital efficiency gains"; the second curve exists today, but it looks more like an extension of the current pest control platform than an independent new business. The factual basis is that Rollins' 2026 investor day medium-term algorithm remains 7%-8% organic growth plus 2%-3% M&A, and it specifically names commercial growth, ancillary services, pricing, and recurring revenue as major drivers; the company's statement did not introduce a new business line outside pest control. In 2025, commercial revenue was 1.245 billion dollars and termite and ancillary services revenue was 782 million dollars, with organic growth of about 7.6% and 9.9%; the 10-K also says ancillary services can deepen existing customer relationships, and the 10-K supports "cross-selling/density improvement" rather than a "new species." By Q1 2026, commercial and termite and ancillary services were still growing 9.6% and 13.5%, respectively, with organic growth of 7.7% and 9.8%, and the Q1 disclosure shows this line is already running. The key here is not launching a revolutionary product, but increasing revenue from each customer, each route, and each service visit: residential customers upgrade to termite protection, commercial customers add compliance frequency, and acquired local companies plug into brand, training, procurement, and back-office systems to keep releasing synergies. The value of AI, routing, and digital tools lies in improving route density, sales conversion, and service consistency, strengthening the execution leverage of the Rollins Way; what really needs verification is whether acquisition returns, ancillary service attach rate, and commercial/termite growth can remain above residential without sacrificing claims performance and customer experience.

Jun 8, 2026
What is its core competitive advantage? Will this moat widen or narrow over the next three to five years?6/10

Conclusion: Rollins' moat is not a quasi-monopoly. It is a compound operating advantage built on "Orkin brand trust + route density + standardized training/processes + an acquisition integration platform," and over the next three to five years it is more likely to remain stable and widen modestly than expand in a step-change. These four links reinforce one another: the brand brings leads, route density lowers cost per service visit, training aligns service standards across new locations, and acquisitions fill regional gaps. Orkin is the key asset. The company says in its 10-K that its global trademark portfolio exceeds 450 marks, and that loss of the Orkin trademark could have a material adverse effect on the overall business. The brand reduces customer acquisition and trial-and-error costs, especially in termite, food/hotel compliance, and home safety contexts. In terms of scale, Rollins had more than 2.8 million customers, more than 850 locations, and about 22,000 employees at the end of 2025; the denser the customer base, the easier it is to spread technician routes, dispatching, advertising, and back-office systems. On process, Orkin's training center has real-world facilities and says each Orkin Pro must complete at least 160 hours of hands-on training in the first year, making service quality more replicable. On acquisitions, the company's medium-term target includes 2%–3% annual growth from acquisitions, while emphasizing retention of acquired brand cultures and sharing of training, technology, and customer service. The moat widens if Rollins can keep buying small companies at reasonable prices and increasing density; the constraints are that pest control still depends on local responsiveness, customers can switch, contract values are not high, and the 10-K acknowledges the industry is fragmented, has low barriers to entry, and includes competitors of different sizes. Rentokil, Ecolab, and strong local operators will all limit pricing and share expansion.

Jun 8, 2026
If its core business is disrupted, does it have the genes for self-reinvention? How does it handle mistakes and bad news?5/10

Conclusion: Rollins has the genes for gradual self-reinvention, but it is not a disruptive company that jumps into entirely new arenas. Its path is mainly digitizing traditional field services, continuing acquisitions, and operating a multi-brand portfolio: the 10-K discloses that BOSS supports service tracking, payment processing, and virtual route management, InSite serves commercial customers, and the company is applying AI to service, operations, and administrative processes; the same 10-K also discloses that it completed 94 acquisitions over the past three years, including 26 in 2025. On brands, Rollins is not betting only on Orkin. It keeps a multi-brand service network including Orkin, HomeTeam, Fox, Saela, and Clark. This shows reinvention through combined improvement in service processes, data systems, brand migration, and local density, not a single product invention. If monitoring hardware, AI dispatching, or customer acquisition platforms reshape the pest control industry, ROL is more likely to keep up through scale, process, and M&A than to stand still.

On bad news, the company can disclose and remediate, but governance cannot receive a full score. In 2022, the SEC alleged improper accounting treatment to meet EPS expectations, and Rollins settled for 8 million dollars, a substantive internal control blemish; in Q1 2026, the company also acknowledged revenue growth of 10.2% and a 120bp decline in operating margin to 16.1%, with pressure from insurance/claims, labor, and sales investment; CFO Kenneth Krause will leave on 2026-06-15, William Harkins will take over, and the company has arranged transition-period advisory support. These disclosures do not package the issues as entirely immaterial, but subsequent numbers still need to validate the fix. Overall, this is not a company that avoids bad news, but investors should keep watching internal controls, margins, and the finance-leadership transition; it is best understood as verifiable capacity for improvement.

Jun 8, 2026
Does management, especially the founder, have a long-term view and deep alignment with the company? Is it willing to sacrifice current profit for the next five to ten years?6/10

Conclusion: Rollins has a long-term anchor, but it is not a full-score management team with the founder still on the front line. The strongest positive is family/trust ownership: the 2026 proxy shows the Significant Shareholder Group held 182.5 million shares, or 37.86%, with the Gary and R. Randall Rollins Voting Trusts each corresponding to 33.25%. This gives major shareholders deep alignment with decade-long compounding and can restrain professional managers' impulse to chase short-term EPS too aggressively. The operating team also speaks in long-term algorithms: the 2026 investor day reiterated 7%-8% organic growth, 2%-3% M&A, 30%-35% core incremental margin, and free cash flow conversion above 100%, showing a willingness to treat modernization, people, route efficiency, and acquisition capability as long-term investments rather than merely squeezing current margins. The report also notes that Q1 2026 margins were dragged down by insurance, labor, and sales investment, while the company still emphasized peak-season improvement and continued investment, which looks more like long-term operation than simple cost cutting. The discounts are equally clear: current CEO Jerry Gahlhoff is a professional manager with personal ownership below 1%, not a founder-entrepreneur; in 2022, the SEC alleged the company made improper accounting adjustments to meet EPS expectations and settled for 8 million dollars, so governance cannot receive a full score; in 2025, the company also repurchased about 200 million dollars of stock at 56.93 dollars in a secondary offering, and price discipline may not have been perfect; the June 2026 CFO transition has a handover arrangement, but the stability of the finance organization still needs watching. Therefore Q6 deserves an upper-middle score: the long-term view exists, and the family anchor is strong, but the evidence that management is willing to sacrifice current profit for five to ten years ahead comes more from stated frameworks and operating investment than from forceful founder-led proof.

Jun 8, 2026
If it disappeared tomorrow, how much would customers miss it? Is its growth sustainable and not dependent on harming society or exploiting regulation?6/10

Conclusion: Customers would clearly miss Rollins, but it is not an irreplaceable public utility. Pest control for termites, rodents, cockroaches, and commercial hygiene compliance is a health and property-protection necessity, not discretionary consumption that can casually be paused; the company says it provides essential residential and commercial pest control and wildlife management services in 71 countries, protecting 2.8 million+ customers and operating 850+ company-owned and franchised locations. More importantly, Rollins' 10-K discloses that residential and commercial pest control is primarily provided on a recurring monthly, bi-monthly, or quarterly basis, while termite maintenance, monitoring, and inspections can also renew annually; when customers miss a service visit, the risk is not buying one fewer product, but pest recurrence, termite damage, or higher compliance pressure in restaurants, hotels, and warehouses. Continuity of service therefore has its own stickiness.

But "being missed" is not the same as having no substitute. Rentokil, Ecolab, and many local pest control providers can still take jobs. ROL's advantage comes more from brand, route density, training, and process than from monopoly. Its growth model is broadly sustainable: management's medium-term algorithm is 7%-8% organic growth and 2%-3% acquisition growth, driven by market growth, pricing, recurring revenue, commercial customers, and ancillary services, not addiction inducement or regulatory arbitrage. The boundaries are clear, however: the 10-K states that the business is subject to environmental, health and safety, and labor regulations, and the EPA also requires restricted-use pesticides to be applied or supervised by certified applicators. If growth were pursued through excessive pesticide use, weaker technician safety, or aggressive acquisitions, social license and regulatory costs would turn against the company.

Jun 8, 2026
What are the unit economics of this business (gross margin, incremental returns)? Do they improve or deteriorate with scale? Where does the money it earns go?7/10

Conclusion: ROL has very strong unit economics, and scale usually makes them better, but Q1 already reminds us this is not a software margin that only moves upward. In 2025, the company had revenue of 3.761 billion dollars and operating profit of 726 million dollars, with an operating margin of 19.3% and adjusted operating margin of 20.0%; based on this, the report calculates simplified 2022-2025 ROIC at about 30%. Gross margin is also thick: Q1 2026 gross margin was still 50.8%, though down 60bp year over year, while operating margin fell to 16.1%, down 120bp, pressured by insurance and claims, labor costs, and sales investment.

The key to incremental economics is low capital intensity and density operations: the denser the routes, the more brand-driven customer acquisition and back-office systems can be spread, so larger scale is likely better. Unlike manufacturing, revenue expansion does not require building factories in lockstep; if new customers fall within existing route and branch density, marginal contribution is usually above average margin. Management's medium-term algorithm is 7%-8% organic growth, 2%-3% M&A, 30%-35% core incremental margin, and FCF conversion >100%. Historical cash quality also supports this: 2025 operating cash flow was about 678 million dollars, free cash flow about 650 million dollars, capital expenditure only 28.09 million dollars, and FCF/net income exceeded 100%. Still, the cost base is mainly labor, while insurance and fleet costs also move with the business; if pricing lags wages, claims, and customer acquisition costs, margins can give back gains in the short term.

The money earned mainly goes to three places: first, continuing to acquire regional pest control companies; second, sustaining dividends, with 2025 cash and stock dividends totaling 327.9 million dollars; third, targeted repurchases during major shareholders' secondary offerings, including about 200 million dollars at 56.93 dollars/share in 2025, after about 300 million dollars in 2023.

Jun 8, 2026
What conditions must all hold for it to rise fivefold in ten years? Are those conditions realistic? What expectations does today's share price imply?2/10

Conclusion: A fivefold gain in ten years is not impossible, but for Rollins it is more of a blue-sky case where all good things happen at once, and its realism is low. Using the common anchor, the 2026-06-05 close was 47.10 dollars, market capitalization was 22.68 billion dollars, PE was 43.2, and forward PE was 37.2; a fivefold share price over ten years requires about 17.5% annualized. If the future valuation falls from 43 times back to 30 times, net income/EPS would need to grow about 7.2 times over ten years, or about 22% annualized, which is clearly harder than the company's medium-term algorithm.

Those conditions include: first, pest control demand and penetration continue to expand steadily; second, the company delivers for a long period on 7%-8% organic growth, 2%-3% acquisition growth, 30%-35% core incremental margin, and free cash flow conversion above 100%; third, the acquisition pipeline is cheap enough and integration runs smoothly; fourth, labor, insurance, claims, and customer acquisition costs do not consume the benefits of price increases. The company did have a high-quality base in 2025: revenue of 3.761 billion dollars, net income of 527 million dollars, and operating cash flow of 678 million dollars, but Q1 2026 revenue grew 10.2%, operating profit grew only 2.0%, and operating margin fell to 16.1%, showing margins do not only move upward.

So today's share price implies that the market already prices it as a high-quality asset with long-term double-digit EPS/FCF compounding, low capital expenditure, high certainty, and a sustainable premium multiple, rather than as an undervalued reversal. If the company merely advances steadily along the path of "high-single-digit organic + low-single-digit acquisitions," the current valuation is already high, and shareholder returns are likely to be absorbed by valuation. To rise fivefold, Rollins would need to exceed management's algorithm and avoid major mistakes for a long time. In short, fivefold requires operating, acquisition, and valuation tailwinds to persist together.

Jun 8, 2026
Why has the market not realized all this yet? Is it too hard to understand, too easy to dismiss, or too far out? What could become the "narrative inflection point"?3/10

Conclusion: The market does not misunderstand Rollins, nor does it look down on the pest control business; it has already priced "high quality" quite fully. What it has not fully granted is the narrative that "this company can still compound at a higher slope for a long time." As of 2026-06-05, ROL still traded at about 43 times earnings, with 18 analysts carrying an average Buy rating and a 62.94 dollars price target, which shows the sell side has not ignored its quality. The issue is that the market understands it is a cash-flow machine, but is not yet willing to extrapolate pricing, acquisition integration, route density, and margin expansion together into a fivefold-in-ten-years story. The disagreement is that the management algorithm is 7%–8% organic growth, 2%–3% contribution from M&A, 30%–35% core incremental margin, and FCF conversion above 100%, but while Q1 2026 revenue grew 10.2% and organic growth was 6.6%, operating margin fell 120bp, as insurance claims, labor, and sales investment consumed part of the compounding. The narrative inflection point is therefore not "everyone suddenly discovers Orkin is strong," but several consecutive quarters proving that organic growth has stabilized back at high single digits, margins recover after peak season, acquisition prices and integration returns can be quantified, the CFO transition goes smoothly, and trust in internal controls continues to recover after the 2022 SEC accounting settlement. In other words, the real catalyst is not a new concept, but an evidence chain that turns a "good business" into a "good business that can still accelerate." Conversely, if organic growth falls below the algorithm, margins remain cost-pressured, M&A returns deteriorate, or the CFO/governance issue triggers another trust discount, the inflection point can also turn downward: the market would re-rate it from a "high-quality compounder" into a "good company with a high valuation and low room for error service roll-up."

Jun 8, 2026

Ask about this report

Members can ask about this report; once answered it appears under "Reader Q&A" on this page. You can also highlight a passage in the text to ask about it directly.